JP2001131041A - Composition for oral use - Google Patents
Composition for oral useInfo
- Publication number
- JP2001131041A JP2001131041A JP31839599A JP31839599A JP2001131041A JP 2001131041 A JP2001131041 A JP 2001131041A JP 31839599 A JP31839599 A JP 31839599A JP 31839599 A JP31839599 A JP 31839599A JP 2001131041 A JP2001131041 A JP 2001131041A
- Authority
- JP
- Japan
- Prior art keywords
- phosphate
- calcium
- mass
- composition
- sodium
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 27
- VSIIXMUUUJUKCM-UHFFFAOYSA-D pentacalcium;fluoride;triphosphate Chemical compound [F-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O VSIIXMUUUJUKCM-UHFFFAOYSA-D 0.000 claims abstract description 17
- 229910052586 apatite Inorganic materials 0.000 claims abstract description 15
- 229910052588 hydroxylapatite Inorganic materials 0.000 claims abstract description 15
- XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 claims abstract description 15
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 claims abstract description 15
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 claims abstract description 10
- 229910052587 fluorapatite Inorganic materials 0.000 claims abstract description 7
- 239000001506 calcium phosphate Substances 0.000 claims description 9
- 235000019731 tricalcium phosphate Nutrition 0.000 claims description 7
- 229910000389 calcium phosphate Inorganic materials 0.000 claims description 6
- 235000011010 calcium phosphates Nutrition 0.000 claims description 6
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 claims description 5
- 239000011777 magnesium Substances 0.000 claims description 5
- 229910052749 magnesium Inorganic materials 0.000 claims description 5
- XZMPQELFUMMFEI-UHFFFAOYSA-A [Ca++].[Ca++].[Ca++].[Ca++].[Ca++].[Ca++].[Ca++].[Ca++].[Ca++].[Ca++].[Ca++].[Ca++].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O Chemical compound [Ca++].[Ca++].[Ca++].[Ca++].[Ca++].[Ca++].[Ca++].[Ca++].[Ca++].[Ca++].[Ca++].[Ca++].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XZMPQELFUMMFEI-UHFFFAOYSA-A 0.000 claims description 3
- 150000003839 salts Chemical class 0.000 claims description 3
- 229910000391 tricalcium phosphate Inorganic materials 0.000 claims description 3
- 229940078499 tricalcium phosphate Drugs 0.000 claims description 3
- 229940077441 fluorapatite Drugs 0.000 claims description 2
- 239000011575 calcium Substances 0.000 abstract description 8
- 229910019142 PO4 Inorganic materials 0.000 abstract description 7
- 159000000003 magnesium salts Chemical class 0.000 abstract description 7
- 239000010452 phosphate Substances 0.000 abstract description 7
- 125000002467 phosphate group Chemical group [H]OP(=O)(O[H])O[*] 0.000 abstract description 6
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 abstract description 4
- 229910052791 calcium Inorganic materials 0.000 abstract description 4
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 abstract description 2
- 238000004321 preservation Methods 0.000 abstract 1
- -1 troches Substances 0.000 description 18
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 12
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 10
- 239000000606 toothpaste Substances 0.000 description 9
- 239000007788 liquid Substances 0.000 description 7
- 238000000926 separation method Methods 0.000 description 7
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 6
- 235000014113 dietary fatty acids Nutrition 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- 239000000194 fatty acid Substances 0.000 description 6
- 229930195729 fatty acid Natural products 0.000 description 6
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 5
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 5
- 239000001768 carboxy methyl cellulose Substances 0.000 description 5
- 235000011187 glycerol Nutrition 0.000 description 5
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 5
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 5
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 5
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 4
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 4
- 241000544066 Stevia Species 0.000 description 4
- 238000011156 evaluation Methods 0.000 description 4
- 239000003205 fragrance Substances 0.000 description 4
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 4
- HELXLJCILKEWJH-NCGAPWICSA-N rebaudioside A Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HELXLJCILKEWJH-NCGAPWICSA-N 0.000 description 4
- 239000011734 sodium Substances 0.000 description 4
- 229910052708 sodium Inorganic materials 0.000 description 4
- 238000003860 storage Methods 0.000 description 4
- 229940034610 toothpaste Drugs 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- MPDGHEJMBKOTSU-YKLVYJNSSA-N 18beta-glycyrrhetic acid Chemical compound C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C(O)=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](O)C1(C)C MPDGHEJMBKOTSU-YKLVYJNSSA-N 0.000 description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 3
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 3
- 239000003082 abrasive agent Substances 0.000 description 3
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 3
- 229910052782 aluminium Inorganic materials 0.000 description 3
- WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 description 3
- 235000010418 carrageenan Nutrition 0.000 description 3
- 239000000679 carrageenan Substances 0.000 description 3
- 229920001525 carrageenan Polymers 0.000 description 3
- 229940113118 carrageenan Drugs 0.000 description 3
- 239000000551 dentifrice Substances 0.000 description 3
- 229960001617 ethyl hydroxybenzoate Drugs 0.000 description 3
- 235000010228 ethyl p-hydroxybenzoate Nutrition 0.000 description 3
- 239000004403 ethyl p-hydroxybenzoate Substances 0.000 description 3
- NUVBSKCKDOMJSU-UHFFFAOYSA-N ethylparaben Chemical compound CCOC(=O)C1=CC=C(O)C=C1 NUVBSKCKDOMJSU-UHFFFAOYSA-N 0.000 description 3
- 230000001771 impaired effect Effects 0.000 description 3
- 239000002324 mouth wash Substances 0.000 description 3
- 229940051866 mouthwash Drugs 0.000 description 3
- 239000002304 perfume Substances 0.000 description 3
- QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 description 3
- 239000000377 silicon dioxide Substances 0.000 description 3
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 3
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 2
- FTLYMKDSHNWQKD-UHFFFAOYSA-N (2,4,5-trichlorophenyl)boronic acid Chemical compound OB(O)C1=CC(Cl)=C(Cl)C=C1Cl FTLYMKDSHNWQKD-UHFFFAOYSA-N 0.000 description 2
- MBDOYVRWFFCFHM-SNAWJCMRSA-N (2E)-hexenal Chemical compound CCC\C=C\C=O MBDOYVRWFFCFHM-SNAWJCMRSA-N 0.000 description 2
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 2
- SLXKOJJOQWFEFD-UHFFFAOYSA-N 6-aminohexanoic acid Chemical compound NCCCCCC(O)=O SLXKOJJOQWFEFD-UHFFFAOYSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- QFOHBWFCKVYLES-UHFFFAOYSA-N Butylparaben Chemical compound CCCCOC(=O)C1=CC=C(O)C=C1 QFOHBWFCKVYLES-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- 108010014251 Muramidase Proteins 0.000 description 2
- 102000016943 Muramidase Human genes 0.000 description 2
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 244000269722 Thea sinensis Species 0.000 description 2
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 2
- 150000001299 aldehydes Chemical class 0.000 description 2
- 235000010443 alginic acid Nutrition 0.000 description 2
- 229920000615 alginic acid Polymers 0.000 description 2
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 2
- 229960002684 aminocaproic acid Drugs 0.000 description 2
- FUWUEFKEXZQKKA-UHFFFAOYSA-N beta-thujaplicin Chemical compound CC(C)C=1C=CC=C(O)C(=O)C=1 FUWUEFKEXZQKKA-UHFFFAOYSA-N 0.000 description 2
- 229960003237 betaine Drugs 0.000 description 2
- 229910000019 calcium carbonate Inorganic materials 0.000 description 2
- JUNWLZAGQLJVLR-UHFFFAOYSA-J calcium diphosphate Chemical compound [Ca+2].[Ca+2].[O-]P([O-])(=O)OP([O-])([O-])=O JUNWLZAGQLJVLR-UHFFFAOYSA-J 0.000 description 2
- FUFJGUQYACFECW-UHFFFAOYSA-L calcium hydrogenphosphate Chemical compound [Ca+2].OP([O-])([O-])=O FUFJGUQYACFECW-UHFFFAOYSA-L 0.000 description 2
- 229940043256 calcium pyrophosphate Drugs 0.000 description 2
- ULDHMXUKGWMISQ-UHFFFAOYSA-N carvone Chemical compound CC(=C)C1CC=C(C)C(=O)C1 ULDHMXUKGWMISQ-UHFFFAOYSA-N 0.000 description 2
- 239000004359 castor oil Substances 0.000 description 2
- 235000019438 castor oil Nutrition 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 235000019821 dicalcium diphosphate Nutrition 0.000 description 2
- RRAFCDWBNXTKKO-UHFFFAOYSA-N eugenol Chemical compound COC1=CC(CC=C)=CC=C1O RRAFCDWBNXTKKO-UHFFFAOYSA-N 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 2
- XMGQYMWWDOXHJM-UHFFFAOYSA-N limonene Chemical compound CC(=C)C1CCC(C)=CC1 XMGQYMWWDOXHJM-UHFFFAOYSA-N 0.000 description 2
- 239000004325 lysozyme Substances 0.000 description 2
- 235000010335 lysozyme Nutrition 0.000 description 2
- 229960000274 lysozyme Drugs 0.000 description 2
- 235000010449 maltitol Nutrition 0.000 description 2
- 239000000845 maltitol Substances 0.000 description 2
- 229940035436 maltitol Drugs 0.000 description 2
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 2
- OSWPMRLSEDHDFF-UHFFFAOYSA-N methyl salicylate Chemical compound COC(=O)C1=CC=CC=C1O OSWPMRLSEDHDFF-UHFFFAOYSA-N 0.000 description 2
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 2
- 229910000392 octacalcium phosphate Chemical group 0.000 description 2
- 239000000049 pigment Substances 0.000 description 2
- 239000004033 plastic Substances 0.000 description 2
- 229920003023 plastic Polymers 0.000 description 2
- NROKBHXJSPEDAR-UHFFFAOYSA-M potassium fluoride Chemical compound [F-].[K+] NROKBHXJSPEDAR-UHFFFAOYSA-M 0.000 description 2
- 235000010232 propyl p-hydroxybenzoate Nutrition 0.000 description 2
- 239000004405 propyl p-hydroxybenzoate Substances 0.000 description 2
- 229960004063 propylene glycol Drugs 0.000 description 2
- 229960003415 propylparaben Drugs 0.000 description 2
- 229940085605 saccharin sodium Drugs 0.000 description 2
- 235000010413 sodium alginate Nutrition 0.000 description 2
- 239000000661 sodium alginate Substances 0.000 description 2
- 229940005550 sodium alginate Drugs 0.000 description 2
- PUZPDOWCWNUUKD-UHFFFAOYSA-M sodium fluoride Chemical compound [F-].[Na+] PUZPDOWCWNUUKD-UHFFFAOYSA-M 0.000 description 2
- BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 description 2
- YIGWVOWKHUSYER-UHFFFAOYSA-F tetracalcium;hydrogen phosphate;diphosphate Chemical group [Ca+2].[Ca+2].[Ca+2].[Ca+2].OP([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O YIGWVOWKHUSYER-UHFFFAOYSA-F 0.000 description 2
- MGSRCZKZVOBKFT-UHFFFAOYSA-N thymol Chemical compound CC(C)C1=CC=C(C)C=C1O MGSRCZKZVOBKFT-UHFFFAOYSA-N 0.000 description 2
- RUVINXPYWBROJD-ONEGZZNKSA-N trans-anethole Chemical compound COC1=CC=C(\C=C\C)C=C1 RUVINXPYWBROJD-ONEGZZNKSA-N 0.000 description 2
- VXYADVIJALMOEQ-UHFFFAOYSA-K tris(lactato)aluminium Chemical compound CC(O)C(=O)O[Al](OC(=O)C(C)O)OC(=O)C(C)O VXYADVIJALMOEQ-UHFFFAOYSA-K 0.000 description 2
- 239000000341 volatile oil Substances 0.000 description 2
- 239000000811 xylitol Substances 0.000 description 2
- 235000010447 xylitol Nutrition 0.000 description 2
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 2
- 229960002675 xylitol Drugs 0.000 description 2
- WTVHAMTYZJGJLJ-UHFFFAOYSA-N (+)-(4S,8R)-8-epi-beta-bisabolol Natural products CC(C)=CCCC(C)C1(O)CCC(C)=CC1 WTVHAMTYZJGJLJ-UHFFFAOYSA-N 0.000 description 1
- NFLGAXVYCFJBMK-RKDXNWHRSA-N (+)-isomenthone Natural products CC(C)[C@H]1CC[C@@H](C)CC1=O NFLGAXVYCFJBMK-RKDXNWHRSA-N 0.000 description 1
- NOOLISFMXDJSKH-KXUCPTDWSA-N (-)-Menthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@H]1O NOOLISFMXDJSKH-KXUCPTDWSA-N 0.000 description 1
- RGZSQWQPBWRIAQ-CABCVRRESA-N (-)-alpha-Bisabolol Chemical compound CC(C)=CCC[C@](C)(O)[C@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-CABCVRRESA-N 0.000 description 1
- QYIXCDOBOSTCEI-QCYZZNICSA-N (5alpha)-cholestan-3beta-ol Chemical compound C([C@@H]1CC2)[C@@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@H](C)CCCC(C)C)[C@@]2(C)CC1 QYIXCDOBOSTCEI-QCYZZNICSA-N 0.000 description 1
- 229940058015 1,3-butylene glycol Drugs 0.000 description 1
- HNAGHMKIPMKKBB-UHFFFAOYSA-N 1-benzylpyrrolidine-3-carboxamide Chemical compound C1C(C(=O)N)CCN1CC1=CC=CC=C1 HNAGHMKIPMKKBB-UHFFFAOYSA-N 0.000 description 1
- SPSPIUSUWPLVKD-UHFFFAOYSA-N 2,3-dibutyl-6-methylphenol Chemical compound CCCCC1=CC=C(C)C(O)=C1CCCC SPSPIUSUWPLVKD-UHFFFAOYSA-N 0.000 description 1
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 1
- IJALWSVNUBBQRA-UHFFFAOYSA-N 4-Isopropyl-3-methylphenol Chemical compound CC(C)C1=CC=C(O)C=C1C IJALWSVNUBBQRA-UHFFFAOYSA-N 0.000 description 1
- AXCXHFKZHDEKTP-NSCUHMNNSA-N 4-methoxycinnamaldehyde Chemical compound COC1=CC=C(\C=C\C=O)C=C1 AXCXHFKZHDEKTP-NSCUHMNNSA-N 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 1
- 108010011485 Aspartame Proteins 0.000 description 1
- SGHZXLIDFTYFHQ-UHFFFAOYSA-L Brilliant Blue Chemical compound [Na+].[Na+].C=1C=C(C(=C2C=CC(C=C2)=[N+](CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=2C(=CC=CC=2)S([O-])(=O)=O)C=CC=1N(CC)CC1=CC=CC(S([O-])(=O)=O)=C1 SGHZXLIDFTYFHQ-UHFFFAOYSA-L 0.000 description 1
- 229910014497 Ca10(PO4)6(OH)2 Inorganic materials 0.000 description 1
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical group [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 1
- 239000005973 Carvone Substances 0.000 description 1
- NPBVQXIMTZKSBA-UHFFFAOYSA-N Chavibetol Natural products COC1=CC=C(CC=C)C=C1O NPBVQXIMTZKSBA-UHFFFAOYSA-N 0.000 description 1
- GHXZTYHSJHQHIJ-UHFFFAOYSA-N Chlorhexidine Chemical class C=1C=C(Cl)C=CC=1NC(N)=NC(N)=NCCCCCCN=C(N)N=C(N)NC1=CC=C(Cl)C=C1 GHXZTYHSJHQHIJ-UHFFFAOYSA-N 0.000 description 1
- 244000060011 Cocos nucifera Species 0.000 description 1
- 235000013162 Cocos nucifera Nutrition 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 1
- 108010001682 Dextranase Proteins 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- WEEGYLXZBRQIMU-UHFFFAOYSA-N Eucalyptol Chemical compound C1CC2CCC1(C)OC2(C)C WEEGYLXZBRQIMU-UHFFFAOYSA-N 0.000 description 1
- 239000005770 Eugenol Substances 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- MPDGHEJMBKOTSU-UHFFFAOYSA-N Glycyrrhetinsaeure Natural products C12C(=O)C=C3C4CC(C)(C(O)=O)CCC4(C)CCC3(C)C1(C)CCC1C2(C)CCC(O)C1(C)C MPDGHEJMBKOTSU-UHFFFAOYSA-N 0.000 description 1
- 229920002907 Guar gum Polymers 0.000 description 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 1
- NFLGAXVYCFJBMK-UHFFFAOYSA-N Menthone Chemical compound CC(C)C1CCC(C)CC1=O NFLGAXVYCFJBMK-UHFFFAOYSA-N 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 241000241413 Propolis Species 0.000 description 1
- HDSBZMRLPLPFLQ-UHFFFAOYSA-N Propylene glycol alginate Chemical compound OC1C(O)C(OC)OC(C(O)=O)C1OC1C(O)C(O)C(C)C(C(=O)OCC(C)O)O1 HDSBZMRLPLPFLQ-UHFFFAOYSA-N 0.000 description 1
- UVMRYBDEERADNV-UHFFFAOYSA-N Pseudoeugenol Natural products COC1=CC(C(C)=C)=CC=C1O UVMRYBDEERADNV-UHFFFAOYSA-N 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- UEDUENGHJMELGK-HYDKPPNVSA-N Stevioside Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O UEDUENGHJMELGK-HYDKPPNVSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- ULUAUXLGCMPNKK-UHFFFAOYSA-N Sulfobutanedioic acid Chemical compound OC(=O)CC(C(O)=O)S(O)(=O)=O ULUAUXLGCMPNKK-UHFFFAOYSA-N 0.000 description 1
- 239000005844 Thymol Substances 0.000 description 1
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 1
- XEFQLINVKFYRCS-UHFFFAOYSA-N Triclosan Chemical compound OC1=CC(Cl)=CC=C1OC1=CC=C(Cl)C=C1Cl XEFQLINVKFYRCS-UHFFFAOYSA-N 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 229940023476 agar Drugs 0.000 description 1
- 235000010419 agar Nutrition 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- 229960000458 allantoin Drugs 0.000 description 1
- RGZSQWQPBWRIAQ-LSDHHAIUSA-N alpha-Bisabolol Natural products CC(C)=CCC[C@@](C)(O)[C@@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-LSDHHAIUSA-N 0.000 description 1
- TUFYVOCKVJOUIR-UHFFFAOYSA-N alpha-Thujaplicin Natural products CC(C)C=1C=CC=CC(=O)C=1O TUFYVOCKVJOUIR-UHFFFAOYSA-N 0.000 description 1
- QYIXCDOBOSTCEI-UHFFFAOYSA-N alpha-cholestanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCCC(C)C)C1(C)CC2 QYIXCDOBOSTCEI-UHFFFAOYSA-N 0.000 description 1
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
- 229910000323 aluminium silicate Inorganic materials 0.000 description 1
- 229940024606 amino acid Drugs 0.000 description 1
- 235000010407 ammonium alginate Nutrition 0.000 description 1
- 239000000728 ammonium alginate Substances 0.000 description 1
- KPGABFJTMYCRHJ-YZOKENDUSA-N ammonium alginate Chemical compound [NH4+].[NH4+].O1[C@@H](C([O-])=O)[C@@H](OC)[C@H](O)[C@H](O)[C@@H]1O[C@@H]1[C@@H](C([O-])=O)O[C@@H](O)[C@@H](O)[C@H]1O KPGABFJTMYCRHJ-YZOKENDUSA-N 0.000 description 1
- 229940011037 anethole Drugs 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 239000007900 aqueous suspension Substances 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 239000000605 aspartame Substances 0.000 description 1
- 235000010357 aspartame Nutrition 0.000 description 1
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 1
- 229960003438 aspartame Drugs 0.000 description 1
- 229960000686 benzalkonium chloride Drugs 0.000 description 1
- UREZNYTWGJKWBI-UHFFFAOYSA-M benzethonium chloride Chemical compound [Cl-].C1=CC(C(C)(C)CC(C)(C)C)=CC=C1OCCOCC[N+](C)(C)CC1=CC=CC=C1 UREZNYTWGJKWBI-UHFFFAOYSA-M 0.000 description 1
- 229960001950 benzethonium chloride Drugs 0.000 description 1
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- 229940036350 bisabolol Drugs 0.000 description 1
- HHGZABIIYIWLGA-UHFFFAOYSA-N bisabolol Natural products CC1CCC(C(C)(O)CCC=C(C)C)CC1 HHGZABIIYIWLGA-UHFFFAOYSA-N 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 235000019437 butane-1,3-diol Nutrition 0.000 description 1
- OBNCKNCVKJNDBV-UHFFFAOYSA-N butanoic acid ethyl ester Natural products CCCC(=O)OCC OBNCKNCVKJNDBV-UHFFFAOYSA-N 0.000 description 1
- 235000010354 butylated hydroxytoluene Nutrition 0.000 description 1
- 229940067596 butylparaben Drugs 0.000 description 1
- 235000001465 calcium Nutrition 0.000 description 1
- 235000010410 calcium alginate Nutrition 0.000 description 1
- 239000000648 calcium alginate Substances 0.000 description 1
- 229960002681 calcium alginate Drugs 0.000 description 1
- XAAHAAMILDNBPS-UHFFFAOYSA-L calcium hydrogenphosphate dihydrate Chemical compound O.O.[Ca+2].OP([O-])([O-])=O XAAHAAMILDNBPS-UHFFFAOYSA-L 0.000 description 1
- 229910001424 calcium ion Inorganic materials 0.000 description 1
- OKHHGHGGPDJQHR-YMOPUZKJSA-L calcium;(2s,3s,4s,5s,6r)-6-[(2r,3s,4r,5s,6r)-2-carboxy-6-[(2r,3s,4r,5s,6r)-2-carboxylato-4,5,6-trihydroxyoxan-3-yl]oxy-4,5-dihydroxyoxan-3-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylate Chemical compound [Ca+2].O[C@@H]1[C@H](O)[C@H](O)O[C@@H](C([O-])=O)[C@H]1O[C@H]1[C@@H](O)[C@@H](O)[C@H](O[C@H]2[C@H]([C@@H](O)[C@H](O)[C@H](O2)C([O-])=O)O)[C@H](C(O)=O)O1 OKHHGHGGPDJQHR-YMOPUZKJSA-L 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical compound OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 description 1
- 229960001927 cetylpyridinium chloride Drugs 0.000 description 1
- YMKDRGPMQRFJGP-UHFFFAOYSA-M cetylpyridinium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCC[N+]1=CC=CC=C1 YMKDRGPMQRFJGP-UHFFFAOYSA-M 0.000 description 1
- 239000002738 chelating agent Substances 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229940112822 chewing gum Drugs 0.000 description 1
- 235000015218 chewing gum Nutrition 0.000 description 1
- 229940099898 chlorophyllin Drugs 0.000 description 1
- 235000019805 chlorophyllin Nutrition 0.000 description 1
- 229960005233 cineole Drugs 0.000 description 1
- RFFOTVCVTJUTAD-UHFFFAOYSA-N cineole Natural products C1CC2(C)CCC1(C(C)C)O2 RFFOTVCVTJUTAD-UHFFFAOYSA-N 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 229940075110 dibasic magnesium phosphate Drugs 0.000 description 1
- 235000019700 dicalcium phosphate Nutrition 0.000 description 1
- 229940105990 diglycerin Drugs 0.000 description 1
- GPLRAVKSCUXZTP-UHFFFAOYSA-N diglycerol Chemical compound OCC(O)COCC(O)CO GPLRAVKSCUXZTP-UHFFFAOYSA-N 0.000 description 1
- QGGZBXOADPVUPN-UHFFFAOYSA-N dihydrochalcone Chemical compound C=1C=CC=CC=1C(=O)CCC1=CC=CC=C1 QGGZBXOADPVUPN-UHFFFAOYSA-N 0.000 description 1
- PXLWOFBAEVGBOA-UHFFFAOYSA-N dihydrochalcone Natural products OC1C(O)C(O)C(CO)OC1C1=C(O)C=CC(C(=O)CC(O)C=2C=CC(O)=CC=2)=C1O PXLWOFBAEVGBOA-UHFFFAOYSA-N 0.000 description 1
- MHJAJDCZWVHCPF-UHFFFAOYSA-L dimagnesium phosphate Chemical compound [Mg+2].OP([O-])([O-])=O MHJAJDCZWVHCPF-UHFFFAOYSA-L 0.000 description 1
- XZTWHWHGBBCSMX-UHFFFAOYSA-J dimagnesium;phosphonato phosphate Chemical compound [Mg+2].[Mg+2].[O-]P([O-])(=O)OP([O-])([O-])=O XZTWHWHGBBCSMX-UHFFFAOYSA-J 0.000 description 1
- HNPSIPDUKPIQMN-UHFFFAOYSA-N dioxosilane;oxo(oxoalumanyloxy)alumane Chemical compound O=[Si]=O.O=[Al]O[Al]=O HNPSIPDUKPIQMN-UHFFFAOYSA-N 0.000 description 1
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 1
- 229940113120 dipropylene glycol Drugs 0.000 description 1
- PXEDJBXQKAGXNJ-QTNFYWBSSA-L disodium L-glutamate Chemical compound [Na+].[Na+].[O-]C(=O)[C@@H](N)CCC([O-])=O PXEDJBXQKAGXNJ-QTNFYWBSSA-L 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 229940009662 edetate Drugs 0.000 description 1
- 229960003720 enoxolone Drugs 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 229960002217 eugenol Drugs 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 230000003631 expected effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000001125 extrusion Methods 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 239000004088 foaming agent Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 229940014259 gelatin Drugs 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 229940049906 glutamate Drugs 0.000 description 1
- 229930195712 glutamate Natural products 0.000 description 1
- 229960005150 glycerol Drugs 0.000 description 1
- 235000010417 guar gum Nutrition 0.000 description 1
- 239000000665 guar gum Substances 0.000 description 1
- 229960002154 guar gum Drugs 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- NFIDBGJMFKNGGQ-UHFFFAOYSA-N isopropylmethylphenol Natural products CC(C)CC1=CC=CC=C1O NFIDBGJMFKNGGQ-UHFFFAOYSA-N 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 150000002596 lactones Chemical class 0.000 description 1
- 235000001510 limonene Nutrition 0.000 description 1
- 229940087305 limonene Drugs 0.000 description 1
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 description 1
- 239000001095 magnesium carbonate Substances 0.000 description 1
- 229910000021 magnesium carbonate Inorganic materials 0.000 description 1
- GVALZJMUIHGIMD-UHFFFAOYSA-H magnesium phosphate Chemical compound [Mg+2].[Mg+2].[Mg+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O GVALZJMUIHGIMD-UHFFFAOYSA-H 0.000 description 1
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 229930007503 menthone Natural products 0.000 description 1
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 1
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 1
- 229960001047 methyl salicylate Drugs 0.000 description 1
- 229960002216 methylparaben Drugs 0.000 description 1
- 229940074371 monofluorophosphate Drugs 0.000 description 1
- 235000013923 monosodium glutamate Nutrition 0.000 description 1
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- RUVINXPYWBROJD-UHFFFAOYSA-N para-methoxyphenyl Natural products COC1=CC=C(C=CC)C=C1 RUVINXPYWBROJD-UHFFFAOYSA-N 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 150000008379 phenol ethers Chemical class 0.000 description 1
- 229960005323 phenoxyethanol Drugs 0.000 description 1
- 229920001495 poly(sodium acrylate) polymer Polymers 0.000 description 1
- 239000004584 polyacrylic acid Substances 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 235000010989 polyoxyethylene sorbitan monostearate Nutrition 0.000 description 1
- 239000001818 polyoxyethylene sorbitan monostearate Substances 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 235000010408 potassium alginate Nutrition 0.000 description 1
- 239000000737 potassium alginate Substances 0.000 description 1
- MZYRDLHIWXQJCQ-YZOKENDUSA-L potassium alginate Chemical compound [K+].[K+].O1[C@@H](C([O-])=O)[C@@H](OC)[C@H](O)[C@H](O)[C@@H]1O[C@@H]1[C@@H](C([O-])=O)O[C@@H](O)[C@@H](O)[C@H]1O MZYRDLHIWXQJCQ-YZOKENDUSA-L 0.000 description 1
- 239000011698 potassium fluoride Substances 0.000 description 1
- 235000003270 potassium fluoride Nutrition 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 235000010409 propane-1,2-diol alginate Nutrition 0.000 description 1
- 239000000770 propane-1,2-diol alginate Substances 0.000 description 1
- 229940069949 propolis Drugs 0.000 description 1
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 description 1
- 229960004172 pyridoxine hydrochloride Drugs 0.000 description 1
- 235000019171 pyridoxine hydrochloride Nutrition 0.000 description 1
- 239000011764 pyridoxine hydrochloride Substances 0.000 description 1
- 230000000395 remineralizing effect Effects 0.000 description 1
- 230000001953 sensory effect Effects 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- RMAQACBXLXPBSY-UHFFFAOYSA-N silicic acid Chemical compound O[Si](O)(O)O RMAQACBXLXPBSY-UHFFFAOYSA-N 0.000 description 1
- 235000012239 silicon dioxide Nutrition 0.000 description 1
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 1
- 235000010234 sodium benzoate Nutrition 0.000 description 1
- 239000004299 sodium benzoate Substances 0.000 description 1
- 229960003885 sodium benzoate Drugs 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000011775 sodium fluoride Substances 0.000 description 1
- 235000013024 sodium fluoride Nutrition 0.000 description 1
- 229940073490 sodium glutamate Drugs 0.000 description 1
- VIZXMHCBZLGUET-UHFFFAOYSA-N sodium gualenate Chemical compound CC(C)C1=CC=C(C)C2=C(S(O)(=O)=O)C=C(C)C2=C1 VIZXMHCBZLGUET-UHFFFAOYSA-N 0.000 description 1
- KSAVQLQVUXSOCR-UHFFFAOYSA-M sodium lauroyl sarcosinate Chemical compound [Na+].CCCCCCCCCCCC(=O)N(C)CC([O-])=O KSAVQLQVUXSOCR-UHFFFAOYSA-M 0.000 description 1
- NNMHYFLPFNGQFZ-UHFFFAOYSA-M sodium polyacrylate Chemical compound [Na+].[O-]C(=O)C=C NNMHYFLPFNGQFZ-UHFFFAOYSA-M 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 229960002920 sorbitol Drugs 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000013112 stability test Methods 0.000 description 1
- 229940013618 stevioside Drugs 0.000 description 1
- OHHNJQXIOPOJSC-UHFFFAOYSA-N stevioside Natural products CC1(CCCC2(C)C3(C)CCC4(CC3(CCC12C)CC4=C)OC5OC(CO)C(O)C(O)C5OC6OC(CO)C(O)C(O)C6O)C(=O)OC7OC(CO)C(O)C(O)C7O OHHNJQXIOPOJSC-UHFFFAOYSA-N 0.000 description 1
- 235000019202 steviosides Nutrition 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 150000005846 sugar alcohols Polymers 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 229920003002 synthetic resin Polymers 0.000 description 1
- 239000000057 synthetic resin Substances 0.000 description 1
- 235000007586 terpenes Nutrition 0.000 description 1
- 229960000790 thymol Drugs 0.000 description 1
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 1
- 229940042585 tocopherol acetate Drugs 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- GYDJEQRTZSCIOI-LJGSYFOKSA-N tranexamic acid Chemical compound NC[C@H]1CC[C@H](C(O)=O)CC1 GYDJEQRTZSCIOI-LJGSYFOKSA-N 0.000 description 1
- 229960000401 tranexamic acid Drugs 0.000 description 1
- MBDOYVRWFFCFHM-UHFFFAOYSA-N trans-2-hexenal Natural products CCCC=CC=O MBDOYVRWFFCFHM-UHFFFAOYSA-N 0.000 description 1
- YSJNWPJHMDWGAA-UHFFFAOYSA-H tricalcium;[oxido-[oxido(phosphonatooxy)phosphoryl]oxyphosphoryl] phosphate Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])(=O)OP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O YSJNWPJHMDWGAA-UHFFFAOYSA-H 0.000 description 1
- 229960003500 triclosan Drugs 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- GFQYVLUOOAAOGM-UHFFFAOYSA-N zirconium(iv) silicate Chemical compound [Zr+4].[O-][Si]([O-])([O-])[O-] GFQYVLUOOAAOGM-UHFFFAOYSA-N 0.000 description 1
- 239000004711 α-olefin Substances 0.000 description 1
- 229930007845 β-thujaplicin Natural products 0.000 description 1
Landscapes
- Cosmetics (AREA)
Abstract
Description
【0001】[0001]
【発明の属する技術分野】本発明は、保存安定性に優れ
た口腔用組成物に関する。TECHNICAL FIELD The present invention relates to an oral composition having excellent storage stability.
【0002】[0002]
【従来の技術】従来より、練歯磨等の口腔用組成物にヒ
ドロキシアパタイト等のアパタイトを配合することによ
り、歯面の再石灰化や歯垢の吸着除去効果を付与するこ
とが知られている。しかしながら、ヒドロキシアパタイ
ト等のアパタイトを含有する練歯磨は、状態が硬くなり
易く、経時的に外観が粗くなり、更には液分離を起こす
など、十分な保存安定性が得られないという問題があ
る。従って、アパタイトを配合した場合における安定性
の確保が望まれている。2. Description of the Related Art It has been known that an apatite such as hydroxyapatite is blended with an oral composition such as toothpaste to impart an effect of remineralizing teeth and adsorbing and removing plaque. . However, toothpastes containing apatite such as hydroxyapatite tend to be hard, have a rough appearance over time, and have a problem that sufficient storage stability cannot be obtained, such as liquid separation. Therefore, it is desired to ensure stability when apatite is blended.
【0003】[0003]
【発明が解決しようとする課題】本発明は、アパタイト
類を含みながらも、保存安定性の高い口腔用組成物を提
供することを目的とする。SUMMARY OF THE INVENTION An object of the present invention is to provide an oral composition containing apatites and having high storage stability.
【0004】[0004]
【課題を解決するための手段】本発明者らは、上記課題
を解決すべく鋭意検討を行った結果、アパタイト類を含
有する口腔用組成物において、マグネシウム塩を組み合
わせて配合することで、高温で長期間保存した場合でも
硬くならず、外観上の滑らかさを維持し、且つ液分離を
起こすことのない安定な口腔用組成物が得られることを
見出し、本発明を完成するに至った。従って本発明は、
ヒドロキシアパタイト、フルオロアパタイト、炭酸アパ
タイト、第三リン酸カルシウム、第四リン酸カルシウム
及び第八リン酸カルシウムからなる群より選ばれる少な
くとも1種を含有する口腔用組成物であって、少なくと
も1種のマグネシウム塩を口腔用組成物の全質量に基づ
いて0.05〜10質量%含有することを特徴とする口腔
用組成物に関する。Means for Solving the Problems The inventors of the present invention have conducted intensive studies to solve the above-mentioned problems, and as a result, by combining a magnesium salt with an oral composition containing apatite, a high temperature is obtained. It has been found that a stable oral composition which does not become hard even when stored for a long period of time, maintains the smoothness in appearance, and does not cause liquid separation, has completed the present invention. Therefore, the present invention
An oral composition comprising at least one selected from the group consisting of hydroxyapatite, fluoroapatite, carbonate apatite, tribasic calcium phosphate, quaternary calcium phosphate, and octacalcium phosphate, wherein at least one magnesium salt contains at least one magnesium salt. The present invention relates to an oral composition characterized by containing 0.05 to 10% by mass based on the total mass of the product.
【0005】[0005]
【発明の実施の形態】以下、本発明につき詳述する。本
明細書中でいう口腔用組成物とは、練歯磨剤、液状歯磨
剤などの歯磨剤類、トローチ剤、クリーム剤、軟膏剤、
添付剤、マウスウォッシュ、口中清涼剤、洗口剤、チュ
ーインガム又はうがい液などを含む。本発明に用いるア
パタイトとは、ヒドロキシアパタイト、フルオロアパタ
イト、炭酸アパタイト、第三リン酸カルシウム、第四リ
ン酸カルシウム及び第八リン酸カルシウムを意味する。
本明細書中では、ヒドロキシアパタイト、フルオロアパ
タイト、炭酸アパタイト、第三リン酸カルシウム、第四
リン酸カルシウム及び第八リン酸カルシウムを総称して
アパタイト類と称する。アパタイト類はそれぞれ以下の
化学式によって表される。 ヒドロキシアパタイト:Ca10(PO4)6(OH)2 フルオロアパタイト:Ca10(PO4)6F2 炭酸アパタイト:CO3Ap 第三リン酸カルシウム:Ca3(PO4)2 第四リン酸カルシウム:Ca4O(PO4)2 第八リン酸カルシウム:Ca8(PO4)6・5H2O これらの中で、特にヒドロキシアパタイトと第三リン酸
カルシウムが好ましく使用される。DESCRIPTION OF THE PREFERRED EMBODIMENTS The present invention will be described below in detail. As used herein, the oral composition includes toothpastes, dentifrices such as liquid dentifrice, troches, creams, ointments,
Includes attachments, mouthwash, mouthwash, mouthwash, chewing gum or gargle. The apatite used in the present invention means hydroxyapatite, fluoroapatite, carbonate apatite, tribasic calcium phosphate, quaternary calcium phosphate and calcium octaphosphate.
In the present specification, hydroxyapatite, fluoroapatite, carbonate apatite, tribasic calcium phosphate, calcium tetraphosphate and calcium octaphosphate are collectively referred to as apatites. Apatites are represented by the following chemical formulas. Hydroxyapatite: Ca 10 (PO 4 ) 6 (OH) 2 Fluoroapatite: Ca 10 (PO 4 ) 6 F 2 Carbonate apatite: CO 3 Ap Calcium phosphate tribasic: Ca 3 (PO 4 ) 2 Quaternary calcium phosphate: Ca 4 O (PO 4) 2 eighth calcium phosphate: at Ca 8 (PO 4) 6 · 5H 2 O among these, hydroxyapatite and tricalcium phosphate are preferably used.
【0006】これらのアパタイト類は、歯や骨の主成分
(無機成分)であり、生体親和性に優れた極めて安全性
の高い素材である。このため、ヒドロキシアパタイトや
第三リン酸カルシウムなどは生体材料として人工関節や
人工歯根などにも用いられる。また、ヒドロキシアパタ
イトは、カルシウムイオン、リン酸イオン、水酸イオン
の位置が様々な微量元素と置換することが知られてお
り、水酸イオンがフッ素イオンに置換したものがフルオ
ロアパタイトとなり、結晶内に炭酸イオンが取り込まれ
ると炭酸アパタイトになる。アパタイト類は一般に合成
品が用いられており、本発明においてもこのような市販
の合成品を用いることができる。これらは特に限定され
るものではないが、白色の水性懸濁液若しくは粉末の状
態で供給され、その平均粒子径は1〜70μmである。
本発明の口腔用組成物におけるヒドロキシアパタイト、
フルオロアパタイト、炭酸アパタイト、第三リン酸カル
シウム、第四リン酸カルシウム及び第八リン酸カルシウ
ムからなる群より選ばれる少なくとも1種の含有量は、
口腔用組成物の全質量に基づいて0.1〜50質量%が適
当であり、好ましくは1〜30質量%である。この量が
0.1質量%に満たないと期待される歯面の再石灰化や、
歯垢の吸着除去効果が発揮されず、一方50質量%を超
えると含有量に見合った効果が得られず使用性を損ねる
場合がある。[0006] These apatites are the main components (inorganic components) of teeth and bones, and are highly safe materials with excellent biocompatibility. For this reason, hydroxyapatite, tribasic calcium phosphate, and the like are used as biomaterials in artificial joints, artificial roots, and the like. In addition, it is known that the positions of calcium ions, phosphate ions, and hydroxyl ions in hydroxyapatite are replaced with various trace elements. When carbonate ions are taken in, it becomes carbonate apatite. Synthetic products are generally used for apatites, and such commercially available synthetic products can also be used in the present invention. These are not particularly limited, but are supplied in the form of a white aqueous suspension or powder, and have an average particle size of 1 to 70 μm.
Hydroxyapatite in the oral composition of the present invention,
Fluorapatite, carbonate apatite, tricalcium phosphate, at least one content selected from the group consisting of quaternary calcium phosphate and octacalcium phosphate,
The amount is suitably from 0.1 to 50% by mass, preferably from 1 to 30% by mass, based on the total mass of the oral composition. This amount
Recalcification of the tooth surface, which is expected to be less than 0.1% by mass,
The effect of removing and removing plaque is not exhibited. On the other hand, if it exceeds 50% by mass, the effect corresponding to the content cannot be obtained, and the usability may be impaired.
【0007】本発明で使用するマグネシウム塩として
は、ピロリン酸マグネシウム、第二リン酸マグネシウム
及び第三リン酸マグネシウムなどから少なくとも1種を
選択して使用することができる。マグネシウム塩は、食
品や歯磨剤などに配合されるリン酸水素カルシウムのヒ
ドロキシアパタイトへの転化を抑制する目的で使用され
ており、市販されているものがある。本発明において
は、これらの市販品を用いることができる。マグネシウ
ム塩の口腔用組成物の全質量に対する含有量は、0.05
〜10質量%であり、好ましくは0.1〜5質量%であ
る。0.05質量%未満では期待される効果が発揮され
ず、10質量%を越えると含有量に見合った効果が得ら
れず、使用性を損ねる場合がある。As the magnesium salt used in the present invention, at least one selected from magnesium pyrophosphate, dibasic magnesium phosphate and tribasic magnesium phosphate can be used. Magnesium salts are used for the purpose of suppressing the conversion of calcium hydrogen phosphate to hydroxyapatite blended in foods, dentifrices, and the like, and some are commercially available. In the present invention, these commercially available products can be used. The content of magnesium salt with respect to the total mass of the oral composition is 0.05.
10 to 10% by mass, preferably 0.1 to 5% by mass. If the amount is less than 0.05% by mass, the expected effect is not exhibited. If the amount exceeds 10% by mass, the effect corresponding to the content cannot be obtained, and the usability may be impaired.
【0008】本発明の口腔用組成物にはその種類に応じ
て、上記成分に加えて、必要により以下の成分を、通常
の使用量の範囲内で配合することができる。 <研磨剤>シリカゲル、沈降性シリカ、火成性シリカ、
アルミノシリケート、ジルコノシリケート、無水ケイ
酸、含水ケイ酸等のシリカ系研磨剤、第二リン酸カルシ
ウム二水和物、第二リン酸カルシウム無水和物、ピロリ
ン酸カルシウム、水酸化アルミニウム、アルミナ、軽質
炭酸カルシウム、重質炭酸カルシウム、炭酸マグネシウ
ム、ケイ酸ジルコニウム、合成樹脂系研磨剤などが挙げ
られ、これらのうち1種または2種以上を併用して用い
ることができる。上記研磨剤の配合量は、組成物全体に
対して3〜60質量%が好ましく、より好ましくは10
〜45質量%である。[0008] In addition to the above components, the following components can be added to the oral composition of the present invention, if necessary, within the usual use amount, depending on the type. <Abrasives> Silica gel, precipitated silica, igneous silica,
Silica-based abrasives such as aluminosilicate, zirconosilicate, silicic anhydride, hydrous silicic acid, dibasic calcium phosphate dihydrate, dibasic calcium phosphate anhydrous, calcium pyrophosphate, aluminum hydroxide, alumina, light calcium carbonate, heavy Examples include calcium carbonate, magnesium carbonate, zirconium silicate, and synthetic resin-based abrasives, and one or more of these can be used in combination. The amount of the abrasive is preferably 3 to 60% by mass, more preferably 10 to 60% by mass, based on the whole composition.
~ 45% by mass.
【0009】<湿潤剤>グリセリン、濃グリセリン、ジ
グリセリン、ソルビット、マルチトール、ジプロピレン
グリコール、プロピレングリコール、1,3-ブチレングリ
コール、ポリエチレングリコール、キシリトール等の多
価アルコール等の1種または2種以上を使用することが
できる。 <粘結剤>カラギーナン(ι、λ、κ)、アルギン酸、
アルギン酸ナトリウム、アルギン酸プロピレングリコー
ルエステル、カルシウム含有アルギン酸ナトリウム、ア
ルギン酸カリウム、アルギン酸カルシウム、アルギン酸
アンモニウム等のアルギン酸塩及びその誘導体、ポリビ
ニルピロリドン、キサンタンガム、グァーガム、ゼラチ
ン、寒天、カルボキシメチルセルロースナトリウム、ヒ
ドロキシエチルセルロース、ポリアクリル酸ナトリウム
などが挙げられ、これらのうち1種または2種以上を併
用して用いることができる。<Wetting agent> One or two kinds of polyhydric alcohols such as glycerin, concentrated glycerin, diglycerin, sorbitol, maltitol, dipropylene glycol, propylene glycol, 1,3-butylene glycol, polyethylene glycol and xylitol. The above can be used. <Binder> carrageenan (ι, λ, κ), alginic acid,
Alginates such as sodium alginate, propylene glycol alginate, sodium alginate containing calcium, potassium alginate, calcium alginate, ammonium alginate and derivatives thereof, polyvinylpyrrolidone, xanthan gum, guar gum, gelatin, agar, sodium carboxymethylcellulose, hydroxyethylcellulose, polyacrylic acid Sodium and the like, and one or more of these can be used in combination.
【0010】<発泡剤>ラウリル硫酸ナトリウム、ラウ
ロイルサルコシンナトリウム、アルキルスルホコハク酸
ナトリウム、ヤシ油脂肪酸モノグリセリンスルホン酸ナ
トリウム、α-オレフィンスルホン酸ナトリウム、、N-
アシルグルタメート等のN-アシルアミノ酸塩、2-アルキ
ル-N-カルボキシメチル-N-ヒドロキシエチルイミダゾリ
ニウムベタイン、マルチトール脂肪酸エステル、ショ糖
脂肪酸エステル、ポリグリセリン脂肪酸エステル、脂肪
酸ジエタノールアミド、ポリオキシエチレンソルビタン
モノステアレート、ポリオキシエチレン硬化ヒマシ油、
ポリオキシエチレン脂肪酸エステル等が挙げられ、これ
らのうち1種または2種以上を併用して用いることがで
きる。<Foaming agent> Sodium lauryl sulfate, sodium lauroyl sarcosine, sodium alkyl sulfosuccinate, sodium coconut fatty acid monoglycerin sulfonate, sodium α-olefin sulfonate, N-
N-acyl amino acid salts such as acyl glutamate, 2-alkyl-N-carboxymethyl-N-hydroxyethylimidazolinium betaine, maltitol fatty acid ester, sucrose fatty acid ester, polyglycerin fatty acid ester, fatty acid diethanolamide, polyoxyethylene Sorbitan monostearate, polyoxyethylene hydrogenated castor oil,
Examples thereof include polyoxyethylene fatty acid esters, and one or more of these can be used in combination.
【0011】<甘味剤>サッカリンナトリウム、アスパ
ルテーム、ステビオサイド、ステビアエキス、パラメト
キシシンナミックアルデヒド、ネオヘスペリジルジヒド
ロカルコン、ペリラルチン等。 <防腐剤>メチルパラベン、エチルパラベン、プロピル
パラベン、ブチルパラベン等のパラベン類、安息香酸ナ
トリウム、フェノキシエタノール、塩酸アルキルジアミ
ノエチルグリシン等。<Sweetening agents> Saccharin sodium, aspartame, stevioside, stevia extract, paramethoxycinnamic aldehyde, neohesperidyl dihydrochalcone, perillartin and the like. <Preservatives> Parabens such as methylparaben, ethylparaben, propylparaben, and butylparaben, sodium benzoate, phenoxyethanol, and alkyldiaminoethylglycine hydrochloride.
【0012】<香料成分>l-メントール、アネトール、
メントン、シネオール、リモネン、カルボン、メチルサ
リシレート、エチルブチレート、オイゲノール、チモー
ル、シンナミックアルデヒド、トランス-2-ヘキセナー
ルなどの中から1種または2種以上を併用して用いるこ
とができる。これらの成分は単品で配合してもよいが、
これらを含有する精油等を配合してもよい。また、上記
香料成分に加え、脂肪族アルコールやそのエステル、テ
ルペン系炭化水素、フェノールエーテル、アルデヒド、
ケトン、ラクトン等の香料成分、精油を本発明の効果を
妨げない範囲で配合してもよい。上記香料の配合量は、
組成物全体に対して0.02〜2質量%とすることが好ま
しい。<Fragrance ingredients> l-menthol, anethole,
One or more of menthone, cineole, limonene, carvone, methyl salicylate, ethyl butyrate, eugenol, thymol, cinamic aldehyde, trans-2-hexenal and the like can be used in combination. These components may be compounded individually,
Essential oils containing these may be blended. Further, in addition to the above flavor components, aliphatic alcohols and esters thereof, terpene hydrocarbons, phenol ethers, aldehydes,
Perfume components such as ketones and lactones, and essential oils may be blended as long as the effects of the present invention are not impaired. The amount of the above fragrance is
The content is preferably set to 0.02 to 2% by mass based on the whole composition.
【0013】<有効成分>塩化リゾチーム、モノフルオ
ロホスフェート、フッ化ナトリウム、フッ化カリウム、
ヒノキチオール、アスコルビン酸、クロルヘキシジン塩
類、トリクロサン、イソプロピルメチルフェノール、塩
化セチルピリジニウム、塩化ベンザルコニウム、塩化ベ
ンゼトニウム、ビサボロール、酢酸トコフェロール、ε
−アミノカプロン酸、トラネキサム酸、アルミニウムヒ
ドロキシルアラントイン、乳酸アルミニウム、ジヒドロ
コレステロール、グリチルレチン酸、グリチルリチン酸
塩類、銅クロロフィリン塩、塩化ナトリウム、グァイア
ズレンスルホン酸塩、デキストラナーゼ、塩酸ピリドキ
シンなどを1種または2種以上を配合することができ
る。<Active ingredient> Lysozyme chloride, monofluorophosphate, sodium fluoride, potassium fluoride,
Hinokitiol, ascorbic acid, chlorhexidine salts, triclosan, isopropylmethylphenol, cetylpyridinium chloride, benzalkonium chloride, benzethonium chloride, bisabolol, tocopherol acetate, ε
One or two of aminocaproic acid, tranexamic acid, aluminum hydroxyl allantoin, aluminum lactate, dihydrocholesterol, glycyrrhetinic acid, glycyrrhizinates, copper chlorophyllin salt, sodium chloride, guaiazulene sulfonate, dextranase, pyridoxine hydrochloride, etc. More than one species can be blended.
【0014】<その他>青色1号等の色素、酸化チタン
等の顔料、ジブチルヒドロキシトルエン等の酸化防止
剤、エデト酸塩等のキレート剤、チャエキス、チャ乾留
液、プロポリスエキス、グルタミン酸ナトリウム等の矯
味剤など。<Others> Pigments such as Blue No. 1, pigments such as titanium oxide, antioxidants such as dibutylhydroxytoluene, chelating agents such as edetate, tea extract, tea distillation, propolis extract, and sodium glutamate. Agents and the like.
【0015】本発明の口腔用組成物は、常法に準じて製
造できるものであり、製法は特に限定されるものではな
い。また、得られた練歯磨剤等の組成物は、アルミニウ
ムチューブ、ラミネートチューブ、ガラス蒸着チュー
ブ、プラスチックチューブ、プラスチックボトル、エア
ゾール容器等に充填されて使用することができる。The oral composition of the present invention can be produced according to a conventional method, and the production method is not particularly limited. Further, the obtained composition such as a toothpaste can be used after being filled in an aluminum tube, a laminate tube, a glass deposition tube, a plastic tube, a plastic bottle, an aerosol container and the like.
【0016】[0016]
【発明の効果】本発明の口腔用組成物は、従来アパタイ
ト類を配合した口腔用組成物に見られる、硬くなる、粗
くなる、また液分離を起こすといった経時的変化が防止
されており、アパタイト類を配合しつつ優れた保存安定
性を発揮することができる。EFFECTS OF THE INVENTION The oral composition of the present invention is capable of preventing changes over time such as hardening, coarsening, and liquid separation, which are conventionally observed in oral compositions containing apatites. While exhibiting excellent storage stability.
【0017】[0017]
【実施例】以下、実験例及び実施例により、本発明を詳
細に説明するが、本発明は下記の実施例に制限されるも
のではない。なお、下記の例に示す%は質量%を意味す
る。 <安定性試験>表1に示す処方(単位:質量%)にて各
種練歯磨剤を常法に準じて調製し、アルミニウムチュー
ブに充填した後、50℃で2ヶ月保存した。これらの保
存品につき、下記の評価基準に基づいて、硬さ、粗さ
(滑らかさ)及び液分離についての官能評価を行った。
その結果を表2に示す。EXAMPLES The present invention will be described in detail below with reference to experimental examples and examples, but the present invention is not limited to the following examples. In addition,% shown in the following examples means mass%. <Stability test> Various toothpastes were prepared according to the conventional method using the formulations (unit: mass%) shown in Table 1, filled in an aluminum tube, and stored at 50 ° C for 2 months. These preserved products were subjected to a sensory evaluation of hardness, roughness (smoothness) and liquid separation based on the following evaluation criteria.
Table 2 shows the results.
【0018】「評価基準」 1)硬さ:チューブからの押し出し易さを触覚的に評
価。 ◎・・・・・柔らかく非常に出し易い。 ○・・・・・ごく普通の硬さで出し易い。 △・・・・・多少硬めでやや出し難い。 ×・・・・・硬めで非常に出し難い。 2)粗さ:チューブから押し出した中身の外観を目視的
に評価 ◎・・・・・非常に滑らかでツヤがある。 ○・・・・・滑らかでややツヤがある。 △・・・・・やや粗く、ツヤがほとんどない。 ×・・・・・粗く全くツヤがない。 3)液分離:歯磨からの液分離を目視的に評価 ◎・・・・・全く分離しない。 ○・・・・・ほとんど分離しない。 △・・・・・わづかに分離している。 ×・・・・・あきらかに分離している。[Evaluation Criteria] 1) Hardness: Tactile evaluation of the ease of extrusion from the tube. ◎ ・ ・ ・ ・ ・ Soft and very easy to put out. ○ ・ ・ ・ ・ ・ ・ ・ It is easy to put out with normal hardness. △ ・ ・ ・ ・ ・ ・ ・ Slightly hard and slightly hard to put out. ×: It is hard and very hard to put out. 2) Roughness: Visually evaluate the appearance of the contents extruded from the tube. A: Very smooth and glossy. ○ ・ ・ ・ ・ ・ ・ ・ Smooth and slightly glossy. △ ・ ・ ・ ・ ・ Slightly rough, almost no gloss. ×: There is no gloss at all. 3) Liquid separation: Liquid separation from toothpaste is visually evaluated. ○ ・ ・ ・ ・ ・ Almost no separation. △ ・ ・ ・ ・ ・ ・ ・ Slightly separated. ×: It is clearly separated.
【0019】[0019]
【表1】 [Table 1]
【0020】[0020]
【表2】 [Table 2]
【0021】以上の実験結果から、本発明による練歯磨
剤は経時安定性に優れていることが判る。また、下記に
示す実施例5〜20の練歯磨剤についても上記の実験を
行ったところ、すべて上記と同様な結果が得られた。以
下、実施例5〜20の練歯磨剤の組成を示す。配合量の
単位は質量%である。From the above experimental results, it can be seen that the toothpaste according to the present invention has excellent stability over time. In addition, when the above-mentioned experiments were carried out also for the toothpastes of Examples 5 to 20 shown below, all the same results were obtained. Hereinafter, the compositions of the toothpastes of Examples 5 to 20 are shown. The unit of the compounding amount is mass%.
【0022】[0022]
【実施例5】 Embodiment 5
【0023】[0023]
【実施例6】 ヒドロキシアパタイト 5.0 第三リン酸マグネシウム 0.5 水酸化アルミニウム 35.0 無水ケイ酸 5.0 濃グリセリン 25.0 カラギーナン 0.5 カルボキシメチルセルロースナトリウム 0.5 ラウリル硫酸ナトリウム 1.5 ステビアエキス 0.1 エチルパラベン 0.1 塩化セチルピリジウム 0.05 香料 1.0水 残 計 100.0Example 6 Hydroxyapatite 5.0 Magnesium tertiary phosphate 0.5 Aluminum hydroxide 35.0 Silicic anhydride 5.0 Concentrated glycerin 25.0 Carrageenan 0.5 Sodium carboxymethyl cellulose 0.5 Sodium lauryl sulfate 1. 5 Stevia extract 0.1 Ethylparaben 0.1 Cetylpyridium chloride 0.05 Perfume 1.0 Water Balance 100.0
【0024】[0024]
【実施例7】 ヒドロキシアパタイト 10.0 第三リン酸マグネシウム 0.5 重質炭酸 30.0 無水ケイ酸 7.0 プロピレングリコール 15.0 ソルビット 15.0 カルボキシメチルセルロースナトリウム 0.6 ポリアクリル酸ナトリウム 0.6 ラウリル硫酸ナトリウム 1.5 サッカリンナトリウム 0.05 塩酸アルキルジアミノエチルグリシン 0.05 β−グリチルレチン酸 0.05 塩酸クトルヘキシジン 0.02 香料 1.0 水 残 計 100.0Example 7 Hydroxyapatite 10.0 Magnesium tertiary phosphate 0.5 Heavy carbonic acid 30.0 Silicic anhydride 7.0 Propylene glycol 15.0 Sorbit 15.0 Sodium carboxymethyl cellulose 0.6 Sodium polyacrylate 0 .6 Sodium lauryl sulfate 1.5 Saccharin sodium 0.05 Alkyl diaminoethyl glycine hydrochloride 0.05 Beta-glycyrrhetinic acid 0.05 Coctylhexidine hydrochloride 0.02 Fragrance 1.0 Water Residue 100.0
【0025】[0025]
【実施例8】 炭酸アパタイト 20.0 第三リン酸マグネシウム 0.1 ピロリン酸カルシウム 30.0 無水ケイ酸 7.0 濃グリセリン 25.0 カラギーナン 0.5 カルボキシメチルセルロースナトリウム 0.5 ポリオキシエチレン硬化ヒマシ油 3.0 ラウリル硫酸ナトリウム 1.5 ステビアエキス 0.1 プロピルパラベン 0.1 塩化リゾチーム 0.4 ε−アミノカプロン酸 0.1 香料 1.0 水 残 計 100.0Example 8 Carbonate Apatite 20.0 Magnesium Tertiary Phosphate 0.1 Calcium Pyrophosphate 30.0 Silicic Anhydride 7.0 Concentrated Glycerin 25.0 Carrageenan 0.5 Sodium Carboxymethyl Cellulose 0.5 Polyoxyethylene Hydrogenated Castor Oil 3.0 Sodium lauryl sulfate 1.5 Stevia extract 0.1 Propyl paraben 0.1 Lysozyme chloride 0.4 ε-Aminocaproic acid 0.1 Perfume 1.0 Water Balance 100.0
【0026】[0026]
【実施例9】 Embodiment 9
【0027】[0027]
【実施例10】 Embodiment 10
【0028】[0028]
【実施例11】 Embodiment 11
【0029】[0029]
【実施例12】 第四リン酸カルシウム 20.0 第三リン酸マグネシウム 10.0 水酸化アルミニウム 15.0 無水ケイ酸 5.0 濃グリセリン 20.0 キシリトール 10.0 カルボキシメチルセルロースナトリウム 1.0 ラウリル硫酸ナトリウム 0.5 2-アルキル-N-カルボキシメチル-N- ヒドロキシエチルイミダゾリウムベタイン 3.0 ステビアエキス 0.1 エチルパラベン 0.1 香料 1.0 乳酸アルミニウム 1.0 水 残 計 100.0Example 12 Calcium quaternary phosphate 20.0 Magnesium tertiary phosphate 10.0 Aluminum hydroxide 15.0 Silicic anhydride 5.0 Concentrated glycerin 20.0 Xylitol 10.0 Sodium carboxymethyl cellulose 1.0 Sodium lauryl sulfate 0 2.5 2-Alkyl-N-carboxymethyl-N-hydroxyethylimidazolium betaine 3.0 Stevia extract 0.1 Ethylparaben 0.1 Fragrance 1.0 Aluminum lactate 1.0 Water Balance 100.0
【0030】[0030]
【実施例13】 Embodiment 13
【0031】[0031]
【実施例14】 Embodiment 14
【0032】[0032]
【実施例15】 Embodiment 15
【0033】[0033]
【実施例16】 Embodiment 16
【0034】[0034]
【実施例17】 Embodiment 17
【0035】[0035]
【実施例18】 Embodiment 18
【0036】[0036]
【実施例19】 Embodiment 19
【0037】[0037]
【実施例20】 Embodiment 20
───────────────────────────────────────────────────── フロントページの続き (51)Int.Cl.7 識別記号 FI テーマコート゛(参考) A61K 7/28 A61K 7/28 (72)発明者 石井 良和 東京都八王子市南大沢2−216−3 光和 クレスト206 Fターム(参考) 4C083 AA112 AB222 AB291 AB292 AB321 AB322 AB372 AB472 AC122 AC132 AC302 AC432 AC472 AC482 AC582 AC622 AC662 AC692 AC712 AC742 AC782 AC792 AC812 AC862 AD092 AD212 AD272 AD352 AD472 AD532 AD662 CC41 DD22 ──────────────────────────────────────────────────の Continued on the front page (51) Int.Cl. 7 Identification symbol FI Theme coat ゛ (Reference) A61K 7/28 A61K 7/28 (72) Inventor Yoshikazu Ishii 2-216-3 Minami-Osawa, Hachioji-shi, Tokyo Mitsuwa Crest 206 F term (reference) 4C083 AA112 AB222 AB291 AB292 AB321 AB322 AB372 AB472 AC122 AC132 AC302 AC432 AC472 AC482 AC582 AC622 AC662 AC692 AC712 AC742 AC782 AC792 AC812 AC862 AD092 AD212 AD272 AD352 AD472 AD532 AD662 CC41 DD22
Claims (1)
イト、炭酸アパタイト、第三リン酸カルシウム、第四リ
ン酸カルシウム及び第八リン酸カルシウムからなる群よ
り選ばれる少なくとも1種を含有する口腔用組成物であ
って、少なくとも1種のマグネシウム塩を口腔用組成物
の全質量に基づいて0.05〜10質量%含有することを
特徴とする口腔用組成物。1. An oral composition containing at least one selected from the group consisting of hydroxyapatite, fluorapatite, carbonate apatite, tricalcium phosphate, tetraquat calcium phosphate and calcium octaphosphate, wherein at least one magnesium An oral composition comprising 0.05 to 10% by mass of a salt based on the total mass of the oral composition.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP31839599A JP4257001B2 (en) | 1999-11-09 | 1999-11-09 | Oral composition |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP31839599A JP4257001B2 (en) | 1999-11-09 | 1999-11-09 | Oral composition |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2001131041A true JP2001131041A (en) | 2001-05-15 |
| JP4257001B2 JP4257001B2 (en) | 2009-04-22 |
Family
ID=18098684
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP31839599A Expired - Lifetime JP4257001B2 (en) | 1999-11-09 | 1999-11-09 | Oral composition |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP4257001B2 (en) |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2013158322A (en) * | 2012-02-07 | 2013-08-19 | Sangi Co Ltd | Calcium phosphate dispersion composition |
| EP2853256A1 (en) * | 2013-09-25 | 2015-04-01 | Credentis AG | Dental care product for tooth whitening |
| WO2015044268A1 (en) * | 2013-09-25 | 2015-04-02 | Credentis Ag | Dental care product for tooth whitening |
| JP2017178912A (en) * | 2016-03-31 | 2017-10-05 | 株式会社松風 | Composition for oral cavity |
| WO2022023523A1 (en) | 2020-07-31 | 2022-02-03 | vVardis AG | Anti-inflammatory and senolytic dental care product with tooth whitening characteristics |
-
1999
- 1999-11-09 JP JP31839599A patent/JP4257001B2/en not_active Expired - Lifetime
Cited By (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2013158322A (en) * | 2012-02-07 | 2013-08-19 | Sangi Co Ltd | Calcium phosphate dispersion composition |
| EP2853256A1 (en) * | 2013-09-25 | 2015-04-01 | Credentis AG | Dental care product for tooth whitening |
| WO2015044268A1 (en) * | 2013-09-25 | 2015-04-02 | Credentis Ag | Dental care product for tooth whitening |
| JP2016533325A (en) * | 2013-09-25 | 2016-10-27 | クレデンティス・アクチェンゲゼルシャフトCredentis AG | Dental care products for whitening teeth |
| RU2673820C2 (en) * | 2013-09-25 | 2018-11-30 | Кредентис Аг | Dental care product for tooth whitening |
| AU2014327234B2 (en) * | 2013-09-25 | 2019-02-21 | Credentis Ag | Dental care product for tooth whitening |
| US10314776B2 (en) | 2013-09-25 | 2019-06-11 | Credentis Ag | Dental care product for tooth whitening |
| JP2017178912A (en) * | 2016-03-31 | 2017-10-05 | 株式会社松風 | Composition for oral cavity |
| WO2022023523A1 (en) | 2020-07-31 | 2022-02-03 | vVardis AG | Anti-inflammatory and senolytic dental care product with tooth whitening characteristics |
Also Published As
| Publication number | Publication date |
|---|---|
| JP4257001B2 (en) | 2009-04-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPS58118509A (en) | Oral composition | |
| KR20130063466A (en) | Dentifrice composition | |
| JP5310556B2 (en) | Oral composition and method for improving astringency of oral composition | |
| JP2002114657A (en) | Base material for composition for oral cavity and composition for oral cavity | |
| JP5168465B2 (en) | Dentifrice composition | |
| JP3693692B2 (en) | Anhydrous toothpaste composition | |
| JP7447470B2 (en) | dentifrice composition | |
| JP2015117215A (en) | Dentifrice composition | |
| JP4257001B2 (en) | Oral composition | |
| JP4632553B2 (en) | Oral composition | |
| JP3189549B2 (en) | Oral composition | |
| JP2003212741A (en) | Toothpaste composition | |
| KR20200141442A (en) | Oral composition and bitter taste improver of α-olefin sulfonate | |
| JP7602910B2 (en) | Oral Composition | |
| JP2018203714A (en) | Oral composition | |
| JP2007161598A (en) | Dentifrice composition | |
| JP2010143842A (en) | Dentifrice composition | |
| JP4257002B2 (en) | Oral composition | |
| CN111315351B (en) | oral composition | |
| JPH111418A (en) | Toothpaste composition | |
| JP4126140B2 (en) | Oral composition | |
| JP2002114656A (en) | Base material for composition for oral cavity and composition for oral cavity | |
| JP4892966B2 (en) | Dentifrice composition | |
| KR102518103B1 (en) | Toothpaste composition | |
| JPH11209255A (en) | Toothpaste composition |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20061109 |
|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20080415 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20080421 |
|
| A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20080619 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20081020 |
|
| A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20081219 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20090126 |
|
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20090202 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20120206 Year of fee payment: 3 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 4257001 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130206 Year of fee payment: 4 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20140206 Year of fee payment: 5 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| EXPY | Cancellation because of completion of term |